High prevalence of Helicobacter pylori clarithromycin resistance mutations among Seattle patients measured by droplet digital PCR

ConclusionsThe prevalence of clarithromycin resistance detected in this region exceeds 20%, indicating that standard triple therapy should not be the first‐line antibiotic treatment for H. pylori infection. Culture‐free assays for detecting clarithromycin resistance mutations can be performed on archived tissue samples and will aid in informing tailored treatment for effective H. pylori eradication.

Source: Helicobacter - February 1, 2018 Category: Gastroenterology Authors: Sarah Talarico, Andrew S. Korson, Christina K. Leverich, Stephanie Park, Florencia G. Jalikis, Melissa P. Upton, Elizabeth Broussard, Nina R. Salama Tags: ORIGINAL ARTICLE Source Type: research